Vir Biotechnology (VIR) Revenue (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Revenue data on file, last reported at $29000.0 in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 99.04% year-over-year to $29000.0; the trailing twelve-month figure through Mar 2026 stood at $65.6 million (up 214.24% YoY), and the FY2025 full-year result was $68.6 million, down 7.61% from the prior year.
• Revenue eased to $29000.0 in Q1 2026, from $64.1 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $1.2 billion in Q1 2022 to a low of $29000.0 in Q1 2026.
• A 5-year average of $113.0 million and a median of $12.4 million in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue jumped 62271.41% in 2022 and plunged 99.3% in 2023, its largest moves.
• Tracing VIR's Revenue over 5 years: stood at $49.4 million in 2022, then sank by 66.03% to $16.8 million in 2023, then retreated by 26.29% to $12.4 million in 2024, then surged by 417.78% to $64.1 million in 2025, then slumped by 99.95% to $29000.0 in 2026.
• Business Quant data shows VIR's Revenue at $29000.0 in Q1 2026, $64.1 million in Q4 2025, and $240000.0 in Q3 2025.